Abstract
The homologous restriction of the complement attack, i.e., the inability of complement to lyse erythrocytes of the same species, has long been known (Bordet 1900), but only in the last decade has progress been made in understanding the nature of this phenomenon. It has become evident that the complement sequence is inhibited species-specifically on the membrane at two steps at least (Shin et al. 1986), thus protecting the erythrocytes against the complement attack. Inhibition is accomplished by two membrane proteins: one, the so-called decay accelerating factor (DAF) which inhibits the complement activation phase (Nicholson-Weller et al. 1982), and the other, the C8 binding protein (C8bp) which interferes with the action of the late complement components (Schönermark et al. 1984, 1986). Since the late complement components C5b-9 represent the cytolytic effector phase of complement, the following discussion will be restricted to the function and characterization of the C8bp.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Betz M, Hänsch GM (1984) Release of arachidonic acid: a new function of the late complement components. Immunobiology 166:473–483
Betz M, Seitz M, Hänsch GM (1987) Thromboxane B2 synthesis in human platelets induced by the late complement components C5b-9. Int Arch Allergy Appl Immunol 82:313–316
Blaas P, Berger B, Weber S, Peter HH, Hänsch GM (1988) Paroxysmal nocturnal hemoglobinuria (PNH) type III: enhanced stimulation of platelets by the terminal complement components is related to the lack of C8bp in the membrane. J Immunol 140:3045–3051
Bordet J (1900) Les serums hemolytique, les antitoxines et les theories des serum cytolytiques. Ann Inst Pasteur 14:257–271
Davitz MA, Low MG, Nussenzweig V (1986) Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C. J Exp Med 163:1150–1161
Devine DV, Siegel RS, Rosse WF (1987) Interaction of the platelets in paroxysmal nocturnal hemoglobinuria with complement. J Clin Invest 79:131–137
Götze O, Müller-Eberhard HJ (1970) Lysis of erythrocytes by complement in the absence of antibody. J exp Med 132:898–903
Hänsch GM, Hammer C, Vanguri P, Shin ML (1981) Self versus nonself restriction in the lysis of erythrocytes by the terminal complement proteins. Proc Natl Acad Sci USA 78:5118–5122
Hänsch GM, Seitz M, Martinotti G, Betz M, Rauterberg EW, Gemsa D (1984) Macrophages release arachidonic acid, prostaglandin E2 and thromboxane in response to the late complement components. J Immunol 133:2145–2150
Hänsch GM, Gemsa D, Resch K (1985) Induction of prostanoid synthesis in human platelets by the late complement components C5b-9 and channel forming antibiotic nystatin: inhibition of reacylation of liberated arachidonic acid. J Immunol 135:1320–1324
Hänsch GM, Schönermark S, Roelcke D (1987) Paroxysmal nocturnal hemoglobinuria type III: lack of an erythrocyte membrane protein restricting the lysis by C5b-9. J Clin Invest 80:7–12
Hänsch GM, Weller P, Nicholson-Weller A (1988) Release of C8bp from the cell membrane by phosphatidylinositol-specific phospholipase C. Blood (in press)
Hu V, Nicholson-Weiler A (1985) Enhanced complement-mediated lysis of type III paroxysmal nocturnal hemoglobinuria erythrocytes involves increased C9 binding and polymerisation. Proc Natl Acad Sci USA 82:5520–5524
Hu V, Shin ML (1984) Species-restricted target cell lysis by human complement. Complement-lysed erythrocytes from different species differ in the ratio of bound and inserted C9. J Immunol 133:2133–2137
Imagawa DK, Osifchin NE, Paznekas WA, Shin ML, Mayer MM (1983) Consequences of cell membrane attack by complement: release of arachidonate and formation of inflammatory mediators. Proc Natl Acad Sci USA 80:6647–6651
Lachmann PJ, Thompson RA (1970) Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C5b6 and the participation of C8 and C9. J Exp Med 131:643–657
Lachmann PJ, Bowyer DE, Nicol P, Dawson RMC, Munn EA (1973) Studies on the terminal stages of complement lysis. Immunology 24:135–145
Lint TF, Behrends CL, Gewurz H (1977) Serum lipoproteins and C567-INH activity. J Immunol 119:883–888
Low MG, Finean JB (1977) Non-lytic release of acetylcholinesterase from erythrocytes by a phospha-tidylinositol-specific phospholipase C. FEBS Lett 82:143–146
Nicholson-Weiler A, Burger J, Fearon DT, Weller PF, Austen KF (1982) Isolation of human erythrocyte membrane glycoprotein with decay-accelerating activity for C3-convertases of the complement system. J Immunol 129:184–189
Packman CH, Rosenfeld SI, Jenkins DE, Thiem PA, Leddy JP (1979) Complement lysis of human erythrocytes. Differing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9. J Clin Invest 64:428–433
Parker CJ, Wiedmer T, Sims PJ, Rosse WF (1985) Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes. J Clin Invest 75:2074–2084
Podack ER, Kolb WP, Müller-Eberhard HJ (1977) The SC5b-7 complex: formation, isolation, properties and subunit composition. J Immunol 119:2024–2029
Podack ER, Kolb WP, Müller-Eberhard HJ (1978) The C5b6 complex: formation, isolation and inhibition of its activity by lipoprotein and the S-protein of human serum. J Immunol 120:1841–1848
Podack ER, Preissner KT, Müller-Eberhard HJ (1984) Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein. Acta Pathol Microbiol Immunol Scand [Suppl] [C] 284:89–96
Polley MJ, Nachman RL, Weksler BB (1981) Human complement in the arachidonic acid transformation pathway in platelets. J Exp Med 153:257–268
Rosenfeld SI, Jenkins DE, Leddy JP (1985) Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria cells does not involve increased C7 binding or cell bound C3b. J Immunol 134:506–510
Rosse WF (1973) Variations in the complement-sensitive cells in paroxysmal nocturnal hemoglobinuria. Br J Haematol 24:327–342
Rosse WF (1986) The control of complement activation by the blood cells ion paroxysmal nocturnal hemoglobinuria. Blood 67:268–269
Rother U, Hänsch GM, Menzel J, Rother K (1974) Deviated lysis: transfer of complement lytic activity to unsensitized cells. Generation of a transferable activity on the surface of complement-resistent bacteria. Z Immunitaetsforsch 148:172–178
Schönermark S, Rauterberg EW, Roelcke D, Löke S, Hänsch GM (1984) A C8-binding protein on the surface of human erythrocytes: the inhibition of lysis in a homologous system (abstract). Immunobiology 168:109
Schönermark S, Rauterberg EW, Shin ML, Löke S, Roelcke D, Hänsch GM (1986) Homologous species restriction in lysis of human erythrocytes. A membrane-derived protein with C8-binding capacity functions as an inhibitor. J Immunol 136:1772–1776
Schönermark S, Filsinger S, Berger B, Hänsch GM (1988) The C8 binding protein of the human erythrocyte: interaction with the components of the complement attack phase. Immunology 63:585–590
Shin ML, Hänsch GM, Hu V, Nicholson-Weller A (1986) Membrane factor(s) responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9. Immunology 136:1777–1782
Tschopp J, Podack ER, Müller-Eberhard HJ (1985) The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization. J Immunol 134:495–499
Yamamoto K (1977) Lytic activity of C5–9 complexes for erythrocytes from species other than sheep: C9 rather than C8-dependent lytic activity. J Immunol 119:1482–1487
Zalman LS, Wood LM, Müller-Eberhard HJ (1986) Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement channels. Proc Natl Acad Sci USA 83:6975–6979
Zalman LS, Wood LM, Frank MM, Müller-Eberhard HJ (1987) Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria. J Exp Med 165:572–577
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Hänsch, G.M. (1988). The Homologous Species Restriction of the Complement Attack: Structure and Function of the C8 Binding Protein. In: Podack, E.R. (eds) Cytotoxic Effector Mechanisms. Current Topics in Microbiology and Immunology, vol 140. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73911-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-73911-8_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73913-2
Online ISBN: 978-3-642-73911-8
eBook Packages: Springer Book Archive